METLIFE INC - Common Stock (MET) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
MET on NYSE
Shares outstanding
658,994,750
Price per share
$78.94
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
480,433,491
Total reported value
$39,554,649,360
% of total 13F portfolios
0.02%
Share change
-6,365,657
Value change
-$497,806,859
Number of holders
1,347
Price from insider filings
$78.94
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of METLIFE INC - Common Stock (MET) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BOARD OF DIRECTORS OF METLIFE INC 16% -0.69% $8,776,507,273 -$139,453,893 106,549,803 -1.6% Board of Directors of MetLife, Inc., as an entity 06 Nov 2025
VANGUARD GROUP INC 11% +13% $5,727,517,119 +$616,204,140 72,555,322 +12% The Vanguard Group 31 Dec 2025

As of 30 Sep 2025, 1,347 institutional investors reported holding 480,433,491 shares of METLIFE INC - Common Stock (MET). This represents 73% of the company’s total 658,994,750 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of METLIFE INC - Common Stock (MET) together control 52% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 9.8% 64,749,521 +13% 0.08% $5,333,418,046
Dodge & Cox 8.1% 53,659,664 +0.9% 2.4% $4,419,946,524
BlackRock, Inc. 7.4% 48,548,827 +2.2% 0.07% $3,998,966,899
STATE STREET CORP 3.9% 25,687,304 -1.3% 0.07% $2,115,863,230
PRICE T ROWE ASSOCIATES INC /MD/ 3.1% 20,591,625 +1.8% 0.18% $1,696,133,000
GEODE CAPITAL MANAGEMENT, LLC 2% 12,871,839 +0.3% 0.07% $1,060,905,853
WELLINGTON MANAGEMENT GROUP LLP 1.9% 12,572,807 +1.5% 0.18% $1,035,622,113
MORGAN STANLEY 1.7% 11,057,801 -2.7% 0.06% $910,831,243
PZENA INVESTMENT MANAGEMENT LLC 1.5% 9,672,023 +5.8% 2.6% $796,684,534
AMERIPRISE FINANCIAL INC 1.2% 7,746,341 +4.8% 0.15% $640,356,746
DIMENSIONAL FUND ADVISORS LP 1.1% 7,489,588 +6% 0.13% $616,896,207
Invesco Ltd. 1% 6,835,387 +3.2% 0.09% $563,030,818
NORTHERN TRUST CORP 1% 6,739,686 -0.75% 0.07% $555,147,935
Clearbridge Investments, LLC 0.92% 6,084,235 +3.2% 0.38% $501,141,348
BANK OF AMERICA CORP /DE/ 0.85% 5,622,529 +7.3% 0.03% $463,127,755
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC 0.77% 5,075,077 -4.3% 0.09% $418,034,092
Bank of New York Mellon Corp 0.75% 4,944,004 -39% 0.07% $407,237,655
NORDEA INVESTMENT MANAGEMENT AB 0.68% 4,512,620 +2% 0.32% $367,643,151
Legal & General Group Plc 0.64% 4,214,132 +6.9% 0.08% $347,118,055
GOLDMAN SACHS GROUP INC 0.62% 4,117,643 +18% 0.05% $339,170,247
JPMORGAN CHASE & CO 0.61% 4,010,859 +4.4% 0.02% $330,384,343
DIAMOND HILL CAPITAL MANAGEMENT INC 0.61% 4,001,662 -2.4% 1.6% $329,616,899
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.57% 3,764,946 -0.89% 0.05% $310,118,602
Amundi 0.55% 3,629,149 -19% 0.1% $298,860,421
Nuveen, LLC 0.52% 3,420,962 -7% 0.07% $281,784,640

Institutional Holders of METLIFE INC - Common Stock (MET) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 6,620,685 $524,119,877 +$32,566,119 $78.94 99
2025 Q3 480,433,491 $39,554,649,360 -$497,806,859 $82.37 1,347
2025 Q2 488,334,439 $39,257,266,955 +$200,225,908 $80.42 1,400
2025 Q1 486,267,655 $39,006,598,020 -$1,436,937,433 $80.29 1,390
2024 Q4 503,759,664 $41,245,637,969 -$316,853,716 $81.88 1,388
2024 Q3 508,189,381 $41,904,922,382 -$1,028,538,911 $82.48 1,306
2024 Q2 519,131,976 $36,439,858,818 -$267,485,359 $70.19 1,293
2024 Q1 523,310,660 $38,759,017,250 -$951,899,478 $74.11 1,266
2023 Q4 536,780,802 $35,512,089,371 -$757,172,566 $66.13 1,259
2023 Q3 546,695,013 $34,393,407,617 -$530,655,451 $62.91 1,176
2023 Q2 552,825,391 $31,257,593,552 -$707,525,908 $56.53 1,162
2023 Q1 565,641,641 $32,762,460,933 -$458,162,144 $57.94 1,196
2022 Q4 571,072,934 $41,326,958,477 -$602,778,823 $72.37 1,299
2022 Q3 577,576,963 $35,126,948,834 -$331,564,993 $60.78 1,174
2022 Q2 582,931,622 $36,591,203,223 -$1,023,901,005 $62.79 1,181
2022 Q1 601,443,856 $42,260,819,491 -$705,350,770 $70.28 1,208
2021 Q4 612,058,094 $38,250,855,668 -$905,449,842 $62.49 1,171
2021 Q3 625,573,904 $38,627,953,774 -$1,226,325,755 $61.73 1,092
2021 Q2 646,616,841 $38,687,586,186 -$1,343,382,317 $59.85 1,108
2021 Q1 667,666,098 $40,588,452,011 -$11,072,666 $60.79 1,060
2020 Q4 669,450,047 $31,430,442,675 -$84,054,082 $46.95 1,025
2020 Q3 675,992,785 $25,117,684,967 -$775,781,938 $37.17 950
2020 Q2 689,951,439 $25,216,851,257 +$280,831,381 $36.52 967
2020 Q1 683,449,026 $20,893,911,254 -$397,748,206 $30.57 938
2019 Q4 687,066,549 $35,016,699,423 -$48,510,918 $50.97 1,092
2019 Q3 689,660,011 $32,520,440,392 -$1,218,278,943 $47.16 1,029
2019 Q2 714,389,620 $35,470,344,764 -$363,592,454 $49.67 1,025
2019 Q1 726,836,515 $30,946,313,869 -$192,079,706 $42.57 1,031
2018 Q4 731,743,806 $30,044,605,690 -$1,444,602,377 $41.06 995
2018 Q3 765,181,919 $35,740,236,792 -$527,060,060 $46.72 995
2018 Q2 777,222,975 $33,889,250,562 -$770,664,414 $43.60 1,017
2018 Q1 794,243,360 $36,448,121,659 -$654,609,958 $45.89 1,017
2017 Q4 808,351,970 $40,866,950,630 -$168,891,471 $50.56 1,076
2017 Q3 809,517,647 $42,032,544,990 +$765,566,366 $51.95 971
2017 Q2 795,021,447 $43,658,924,320 -$553,682,810 $54.94 1,019
2017 Q1 806,339,711 $42,594,339,432 +$2,051,964,293 $52.82 1,039
2016 Q4 832,965,287 $44,878,170,975 +$201,473,745 $53.89 1,027
2016 Q3 827,575,968 $36,748,518,236 +$124,451,728 $44.43 946
2016 Q2 825,186,045 $32,864,198,152 +$117,366,956 $39.83 970
2016 Q1 821,347,834 $36,081,766,503 -$548,883,787 $43.94 954
2015 Q4 830,944,752 $40,057,230,155 -$580,022,092 $48.21 975
2015 Q3 842,579,437 $39,723,169,750 -$367,567,459 $47.15 952
2015 Q2 853,007,627 $47,744,406,658 +$762,939,800 $55.99 964
2015 Q1 835,397,771 $42,223,165,071 -$1,001,607,736 $50.55 927
2014 Q4 855,210,131 $46,240,311,206 +$1,757,096,201 $54.09 947
2014 Q3 819,620,313 $44,026,234,952 -$1,644,634,077 $53.72 881
2014 Q2 848,991,301 $47,160,333,918 +$1,853,970,029 $55.56 895
2014 Q1 815,646,519 $43,060,040,044 +$316,850,182 $52.80 903